best syringe for retatrutide Delivers Bariatric-Level Weight Loss in Pivotal Phase 3 TRIUMPH-1 Trial TikTok influencers fuelling parallel market

Discontinuation rate: 18.2% at 12mg due to adverse events

After 4 weeks of 0.25 mg, increase dose to 0.5 mg once weekly

This treatment targets three key hormone pathways

Durability and Sustained Weight Loss Clinical trials show that weight loss from GLP-1 receptor agonists is sustained over time, particularly when combined with lifestyle changes

DECLARATIONS Authors contributions Performed literature search, review writing, data analysis, and interpretation: Ding M Made significant contributions to the conception, design, and revision of the manuscript: Luo Y Proposed the rationale and framework of review, provided guidance for manuscript design: Ji L Availability of data and materials Not applicable

Most clinical trials are conducted using standard, increasing therapeutic doses, meaning the effectiveness and safety of very low doses are largely unstudied and unvalidated